Matches in Nanopublications for { ?s ?p "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- NP469433.RAZK241Q9TGyZrdp8RAog9wNCrHJIqKZAPxSY84R2-0Ok130_assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469433.RAZK241Q9TGyZrdp8RAog9wNCrHJIqKZAPxSY84R2-0Ok130_provenance.
- assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP469424.RANqjnuNupTVh1V1zMtSbpUciNTlAIN9NNJW26j415wtA130_assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469424.RANqjnuNupTVh1V1zMtSbpUciNTlAIN9NNJW26j415wtA130_provenance.
- NP469434.RAtgwEdmlnpLAuzMZUW7VebroJ1AQZkf41oV6ngKQRgBM130_assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469434.RAtgwEdmlnpLAuzMZUW7VebroJ1AQZkf41oV6ngKQRgBM130_provenance.